openPR Logo
Press release

Retinoic Acid Market Business Growth Statistics and Key Players Insights: LGM Pharma, GF Health Products, Inc., GYMA Laboratories of America, Inc., Genemed Synthesis Inc., IMCoPharma a. s. and others

11-20-2018 12:44 PM CET | Health & Medicine

Press release from: Allied Market Research

Retinoic Acid Market

Retinoic Acid Market

Rise in incidences of cancers as retinoids find an important application in cancer therapeutics drive the Retinoic Acid Market. In addition, retinoic acid is widely used for the treatment of photoaged skin, psoriasis, skin lesions of Kaposis sarcoma, and for cancers of breast and prostate also fuel the Retinoic Acid Market growth. However, isotretinoin; a form of retinoic acid; is highly teratogenic.

As teratogenic drug can disturb the development of an embryo, therefore the use of retinoic acid is strictly controlled. This restrains the market growth. Conversely, increase in research for the cure of cancers and advancements in cancer therapeutics provide ample opportunities for the Retinoic Acid Market growth.

Retinoic acid is a metabolite of vitamin A (retinol) that mediates the functions of vitamin A required for growth and development. It is a member of family of retinoids, that are compound either derived from vitamin A or are structurally similar to it.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-toc-and-sample/4051?utm_source=sy-Openpr

The key players operating in the market include
• LGM Pharma
• GF Health Products Inc.
• GYMA Laboratories of America Inc.
• Genemed Synthesis Inc.
• IMCoPharma a. s.
• Chongqing Huabang Pharmacy Co. Ltd.
• Olon S.p.A.
• Sun Pharmaceutical Industries Ltd.

The retinoic acid market is segmented on the basis of mode of administration, end user, and region. Based on mode of administration, the market is categorized into oral retinoids and external retinoids. By end user, it is classified into hospital pharmacy, retail pharmacy, and online pharmacy. By geography, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

For More Information @ https://www.alliedmarketresearch.com/purchase-enquiry/4051?utm_source=sy-Openpr

Key Benefits
• The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
• Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
• Key players are profiled and their strategies are analyzed thoroughly, which explains the competitive outlook of the global market.
• The report offers a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.

Access Full Summery @ https://www.alliedmarketresearch.com/retinoic-acid-market?utm_source=sy-Openpr

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Retinoic Acid Market Business Growth Statistics and Key Players Insights: LGM Pharma, GF Health Products, Inc., GYMA Laboratories of America, Inc., Genemed Synthesis Inc., IMCoPharma a. s. and others here

News-ID: 1385413 • Views:

More Releases from Allied Market Research

Smart Railway Market to Surge at CAGR of 12.8% -2027 | Huawei Technologies Co., Ltd., BOMBARDIER INC
Smart Railway Market to Surge at CAGR of 12.8% -2027 | Huawei Technologies Co., …
𝐒𝐦𝐚𝐫𝐭 𝐑𝐚𝐢𝐥𝐰𝐚𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 by System (Passenger Information System, Rail & Freight Operations Management System, Smart Safety & Security Monitoring System, Rail communication & Networking System, Smart Ticketing System, Rail Analytics System, and Others) and Offering Type (Solutions, Components & Devices, and Services): Global Opportunity Analysis and Industry Forecast, 2020-2027" According to the report published by Allied Market Research, The global smart railway market size was valued at $18,304.8 million in
Speech Analytics Market Expected to Reach to USD 4.9 Billion by 2031, Key Factors behind Market's Exponential Growth
Speech Analytics Market Expected to Reach to USD 4.9 Billion by 2031, Key Factor …
Allied Market Research published a new report, titled, " The Speech Analytics Market Expected to Reach to USD 4.9 Billion by 2031, Key Factors behind Market's Exponential Growth." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding
Artificial Intelligence in Construction Market Expected to Reach USD 8.6 Billion by 2031, Growing with at a CAGR of 34.1%
Artificial Intelligence in Construction Market Expected to Reach USD 8.6 Billion …
According to the report published by Allied Market Research, The Artificial Intelligence in Construction Market Expected to Reach USD 8.6 Billion by 2031, Growing with at a CAGR of 34.1%. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers valuable able guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining
Seaweed Extracts Market to See Competition Rise | $3.5 Billion by 2032
Seaweed Extracts Market to See Competition Rise | $3.5 Billion by 2032
The seaweed extracts market was valued at $2 billion in 2022, and is estimated to reach $3.5 billion by 2032, growing at a CAGR of 6.1% from 2023 to 2032. Request Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/A12569 Seaweed extracts refer to concentrated substances derived from different types of seaweed or marine algae. These extracts are obtained through various extraction methods, such as drying, grinding, or chemical processes, resulting in highly potent forms

All 5 Releases


More Releases for Retinoic

Retinoic Acid Market 2021 Emerging Players, Growth Analysis And Precise Outlook …
Global Retinoic Acid Market Size, Status And Forecast 2021-2027 Global Retinoic Acid Market Size research report with COVID-19 impact is considered to be an accurate and deep assessment of the present industrial conditions along with the overall Retinoic Acid market size estimated from 2021 to 2027. The study report also showcases a comprehensive analysis of the leading business programs, Retinoic Acid future market share, and business-oriented planning, etc. The report investigates
Retinoic Acid Receptors (RARs) Agonist Market 2020 Research and Clinical Survey …
Retinoic Acid Receptors (RARs) Agonist -Pipeline Insight, 2020 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Retinoic Acid Receptors (RARs) Agonist Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every
Global Market Data - Global Retinoic Acid Receptor Alpha Sales Market Report 201 …
The Global Retinoic Acid Receptor Alpha Sales Market Report 2018 is in-depth study of overall Retinoic Acid Receptor Alpha market including introduction of product, definition, scope, Retinoic Acid Receptor Alpha global sale, and forecast up to 2025. The Retinoic Acid Receptor Alpha industry Data report clarifies the past experience and trends, on the basis of these past experiences, it offers the future prediction considering other factors influencing the growth rate. This worldwide report offers the detailed analysis of the
Retinoic Acid Receptor Alpha Market Expected to Rise Steadily throughout 2018 to …
The research report, titled "Global Retinoic Acid Receptor Alpha Market Report 2023," offers an unmistakable understanding of the topic. The exploration report tries to appreciate the leading-edge techniques taken by vendors in the overall market to offer product detachment through Porter's five forces analysis. It likewise points out the courses in which these associations can strengthen their stand in the market and increment their livelihoods in the coming years. Consistent
Global Retinoic Acid Market– Strategic Assessment and Forecast Till 2022
In this report, the AsiaPacific Retinoic Acid Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split AsiaPacific into several key Regions, with sales K MT, revenue Million USD, market share and growth rate of Retinoic Acid for these regions, from 2012 to 2022 forecast,
New Report Offers Analysis and Insights on Retinoic Acid Receptor Alpha- Pipelin …
The pipeline report, titled “Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Pipeline Review, H2 2017” has been included in the extensive research repository of Market Research Hub (MRH) recently. It reflects the analysis done on RAR for the second half of 2017. Retinoic Acid Receptor Alpha, a nuclear receptor, is encoded by RARA gene. RARA plays a vital